Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Trading Statement

13 May 2008 06:09

RNS Number : 2561U
MicroEmissive Displays Group PLC
13 May 2008
Β 

ο»Ώ

For immediate release: 13 May 2008

MicroEmissive Displays Group plc

("MED" or "the Company")

Trading Statement & Directorate Change

MED, the AIM listed designer and manufacturer of low power microdisplays, provides the following update on current trading.Β 

Discussions with potential customers remain positive and MED has now shipped in excess of 100,000 units to three global headset manufacturers. In addition, the Company can also report nine recent design wins with potential customers who are in the process of designing its revolutionary product, eyescreenβ„’ into their end products. MED is also in discussion with two of Asia's leading digital camera manufacturers regarding the further application of eyescreenβ„’.

From a manufacturing perspective, the Dresden plant continues to perform well with manufacturing yields in line with the Board's expectations.

However, as a result of a general slow down in the demand for consumer electronics world-wide and a slower than anticipated development of the market for consumer head mounted displays, the Board now expects the Company to achieve month-on-month profitability during the next financial year.Β 

The Company also announces today that Paul van Eynde, Director of Sales and Marketing left the employment of MED, and the Board, on 12 May 2008. Bill Miller, Chief Executive of MED, will take responsibility for the Sales and Marketing function and Graeme Walker, Chief Financial Officer, will take responsibility for Operations whilst a permanent replacement is sought.

Commenting on outlook, Bill Miller said: "We are confident that the prospects for eyescreenβ„’ remain very exciting indeed. The delay in the development of the market for consumer head mounted displays has been disappointing but we are still confident that the goals for MED can be met albeit slightly later than expected."

He added: "The design-in activity remains strong and feedback from customers is extremely positive, which gives us confidence in the future performance of the Company."

-ends-

For further information, please contact:Β www.microemissive.com

MicroEmissive Displays

Bill Miller, Chief Executive

0131 650 7764

Tavistock Communications

Matt Ridsdale

Andrew Dunn

Β 

020 7920 3150

Arbuthnot SecuritiesΒ 

Neil Kirton

John Prior

020 7012 2000

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTATMRTMMABBFP
Date   Source Headline
14th Jan 201911:34 amRNSChange of Name
7th Jan 20197:00 amRNSTrading Update
14th Dec 20181:05 pmRNSHolding(s) in Company
13th Dec 20188:30 amRNSDirector/PDMR Shareholding
12th Dec 20181:24 pmRNSResults of General Meeting and Total Voting Rights
12th Dec 20187:00 amRNSResults of Open Offer
27th Nov 20183:35 pmRNSAI database exceeds 1 million images
26th Nov 20187:00 amRNSPlacing to raise £5.0m
23rd Nov 20183:56 pmRNSMedaPhor commences clinical trial for AnatomyGuide
13th Nov 20187:00 amRNSQuality control on ultrasound for HAPIN trial
9th Nov 20187:00 amRNSINTERGROWTH-21st Project the University of Oxford
10th Oct 20182:59 pmRNSHolding(s) in Company
9th Oct 20188:01 amRNSDirector/PDMR Shareholding
8th Oct 20187:00 amRNSPayment of deferred consideration
25th Jul 20187:00 amRNSHalf-year Report
23rd Jul 20187:00 amRNSMedaphor expands ScanNav AI pilot
7th Jun 20187:00 amRNSScanTrainer at Central Middlesex Hospital
30th May 20187:00 amRNSGrant of Options
29th May 20187:00 amRNSBodyWorks Eve installed at NYU School of Medicine
17th May 201810:54 amRNSResult of AGM
17th May 20187:00 amRNSAGM Statement
14th May 20187:00 amRNSScanNav AI software featured on ITV
24th Apr 20187:00 amRNSNotice of AGM
21st Mar 20187:00 amRNSFinal Results
5th Mar 20187:00 amRNSNotice of Results
21st Feb 20187:00 amRNSOpening of Hong Kong office
19th Feb 20187:00 amRNSLaunch of new Point-of-Care Ultrasound simulator
12th Feb 20187:00 amRNSPilot of ultrasound AI software for pregnancy scan
7th Feb 20187:00 amRNSInvestor presentation
5th Feb 20187:00 amRNSInnovate UK grant award confirmed
3rd Jan 20187:00 amRNSTrading and IUL integration update
23rd Nov 20177:00 amRNSInnovate UK Grant Award
30th Oct 20173:19 pmRNSDirector Appointment
18th Oct 201712:46 pmRNSHolding(s) in Company
17th Oct 201711:05 amRNSSecond Price Monitoring Extn
17th Oct 201711:00 amRNSPrice Monitoring Extension
11th Oct 20178:17 amRNSHolding(s) in Company
10th Oct 20171:55 pmRNSHolding(s) in Company
9th Oct 20173:23 pmRNSHolding(s) in Company
9th Oct 20172:51 pmRNSHolding(s) in Company
6th Oct 20178:00 amRNSCompletion of Acquisition
5th Oct 201711:18 amRNSResult of General Meeting
21st Sep 20171:31 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSContract awarded at Mohawk College in Canada
19th Sep 20173:40 pmRNSAcquisition & Placing
17th Aug 20177:00 amRNSInstallation of 500th simulation system
10th Aug 20178:37 amRNSPayment of deferred consideration
31st Jul 20177:00 amRNSHalf-year Report
24th Jul 20177:00 amRNSMedaPhor wins first ScanTrainer customer in India
23rd May 201711:44 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.